Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$128.64 - $184.79 $1.16 Million - $1.67 Million
-9,024 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$160.2 - $186.42 $19,384 - $22,556
121 Added 1.36%
9,024 $1.6 Million
Q1 2021

Apr 19, 2021

BUY
$150.19 - $173.5 $32,591 - $37,649
217 Added 2.5%
8,903 $1.46 Million
Q4 2020

Jan 29, 2021

SELL
$140.71 - $165.05 $9,568 - $11,223
-68 Reduced 0.78%
8,686 $1.43 Million
Q3 2020

Oct 30, 2020

SELL
$105.46 - $144.13 $5,062 - $6,918
-48 Reduced 0.55%
8,754 $1.25 Million
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $9,759 - $12,431
102 Added 1.17%
8,802 $971,000
Q1 2020

Apr 16, 2020

BUY
$87.74 - $152.74 $11,318 - $19,703
129 Added 1.51%
8,700 $868,000
Q4 2019

Jan 29, 2020

SELL
$117.65 - $153.73 $15,176 - $19,831
-129 Reduced 1.48%
8,571 $1.28 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $13,644 - $15,613
109 Added 1.27%
8,700 $1.12 Million
Q2 2019

Jul 17, 2019

SELL
$125.55 - $144.48 $40,050 - $46,089
-319 Reduced 3.58%
8,591 $1.23 Million
Q1 2019

Apr 22, 2019

BUY
$121.81 - $142.95 $487 - $571
4 Added 0.04%
8,910 $1.27 Million
Q4 2018

Jan 22, 2019

BUY
$115.94 - $166.74 $6,840 - $9,837
59 Added 0.67%
8,906 $1.1 Million
Q3 2018

Oct 23, 2018

SELL
$161.01 - $180.57 $199,652 - $223,906
-1,240 Reduced 12.29%
8,847 $1.49 Million
Q2 2018

Jul 12, 2018

SELL
$146.33 - $183.18 $97,748 - $122,364
-668 Reduced 6.21%
10,087 $1.74 Million
Q1 2018

Apr 25, 2018

SELL
$135.59 - $157.16 $225,350 - $261,199
-1,662 Reduced 13.38%
10,755 $1.62 Million
Q4 2017

Feb 12, 2018

SELL
$131.06 - $150.39 $64,481 - $73,991
-492 Reduced 3.81%
12,417 $1.67 Million
Q3 2017

Oct 23, 2017

SELL
$142.62 - $155.6 $497,315 - $542,577
-3,487 Reduced 21.27%
12,909 $1.81 Million
Q2 2017

Aug 09, 2017

BUY
N/A
16,396
16,396 $2.55 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Wolf Group Capital Advisors Portfolio

Follow Wolf Group Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Wolf Group Capital Advisors with notifications on news.